Skip to content

ELDN - Eledon Pharmaceuticals, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchE

Eledon Pharmaceuticals Inc

ELDN · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

E

ELDNEledon Pharmaceuticals Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $4.60
52-wk low: $1.35
Prev close: $2.86
Mkt cap: $288.5M
Fwd P/E: 5.4x
Beta: 0.96

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$39.0M

MI
Millennium
Israel Englander · Q2 2026 13F
$3.9M
position
AQ
AQR
Q2 2026 13F

Earnings

Reported Aug 13, 2026

Earnings landed in line with what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Forward P/E: 5.39
Market cap: $288M

Valuation

P/B8.90

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: ELDN
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $288.48M
Beta: 0.96

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/B

8.9x

Profit margin

+0.0%

Op margin

+0.0%

ROE

-110.7%

$2.3M

position

BH

Brevan Howard

Alan Howard · Q2 2026 13F

$1.2M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for ELDN

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.19+0.0%

-$0.19 expected

Next report

What the street expects next

EPS expected

-$0.19

-$0.20 to -$0.15

Revenue expected

$0.00

5 analysts

Last 30 days

2up0down

Analysts raising estimates

-110.7%

ROA-39.0%

Growth

Beta0.96